Ballentine Partners, LLC Eli Lilly & CO Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ballentine Partners, LLC holds 16,981 shares of LLY stock, worth $13.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
16,981
Previous 16,380 3.67%
Holding current value
$13.2 Million
Previous $14.8 Million 1.44%
% of portfolio
0.26%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$772.14 - $960.02 $464,056 - $576,972
601 Added 3.67%
16,981 $15 Million
Q2 2024

Aug 06, 2024
BUY
$724.87 - $909.04 $829,976 - $1.04 Million
1,145 Added 7.52%
16,380 $14.8 Million
Q1 2024

Apr 11, 2024
BUY
$592.2 - $792.28 $853,952 - $1.14 Million
1,442 Added 10.45%
15,235 $11.9 Million
Q4 2023

Jan 23, 2024
BUY
$525.19 - $619.13 $561,428 - $661,849
1,069 Added 8.4%
13,793 $8.04 Million
Q3 2023

Oct 19, 2023
BUY
$434.7 - $599.3 $161,708 - $222,939
372 Added 3.01%
12,724 $6.83 Million
Q2 2023

Jul 26, 2023
BUY
$350.74 - $468.98 $221,667 - $296,395
632 Added 5.39%
12,352 $5.79 Million
Q1 2023

Apr 27, 2023
BUY
$310.63 - $364.82 $1.46 Million - $1.71 Million
4,697 Added 66.88%
11,720 $4.02 Million
Q4 2022

Jan 27, 2023
BUY
$321.55 - $374.67 $158,845 - $185,086
494 Added 7.57%
7,023 $0
Q3 2022

Oct 26, 2022
BUY
$296.48 - $337.87 $418,036 - $476,396
1,410 Added 27.54%
6,529 $2.11 Million
Q2 2022

Aug 09, 2022
BUY
$278.73 - $327.27 $154,695 - $181,634
555 Added 12.16%
5,119 $1.66 Million
Q1 2022

May 05, 2022
BUY
$234.69 - $291.66 $105,610 - $131,247
450 Added 10.94%
4,564 $1.31 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $76,449 - $94,873
340 Added 9.01%
4,114 $1.14 Million
Q3 2021

Oct 27, 2021
BUY
$221.6 - $272.71 $10,636 - $13,090
48 Added 1.29%
3,774 $872,000
Q2 2021

Aug 12, 2021
SELL
$180.55 - $233.54 $7,222 - $9,341
-40 Reduced 1.06%
3,726 $855,000
Q1 2021

May 11, 2021
BUY
$164.32 - $212.72 $8,216 - $10,636
50 Added 1.35%
3,766 $704,000
Q4 2020

Jan 25, 2021
SELL
$130.46 - $172.63 $203,517 - $269,302
-1,560 Reduced 29.57%
3,716 $627,000
Q3 2020

Oct 22, 2020
BUY
$146.22 - $169.13 $39,625 - $45,834
271 Added 5.41%
5,276 $781,000
Q2 2020

Jul 31, 2020
BUY
$136.42 - $164.18 $11,186 - $13,462
82 Added 1.67%
5,005 $821,000
Q1 2020

Apr 23, 2020
BUY
$119.05 - $147.35 $69,644 - $86,199
585 Added 13.49%
4,923 $683,000
Q4 2019

Jan 22, 2020
BUY
$106.92 - $132.43 $7,912 - $9,799
74 Added 1.74%
4,338 $570,000
Q3 2019

Oct 21, 2019
SELL
$106.79 - $116.16 $6,727 - $7,318
-63 Reduced 1.46%
4,264 $477,000
Q2 2019

Jul 25, 2019
BUY
$110.79 - $129.32 $85,419 - $99,705
771 Added 21.68%
4,327 $480,000
Q1 2019

May 09, 2019
BUY
$111.31 - $131.02 $23,041 - $27,121
207 Added 6.18%
3,556 $461,000
Q4 2018

Feb 04, 2019
SELL
$105.9 - $118.64 $147,306 - $165,028
-1,391 Reduced 29.35%
3,349 $387,000
Q3 2018

Oct 30, 2018
BUY
$85.86 - $107.31 $10,474 - $13,091
122 Added 2.64%
4,740 $509,000
Q2 2018

Jul 19, 2018
BUY
$75.7 - $86.88 $3,255 - $3,735
43 Added 0.94%
4,618 $394,000
Q1 2018

Apr 26, 2018
SELL
$74.21 - $87.6 $42,077 - $49,669
-567 Reduced 11.03%
4,575 $354,000
Q4 2017

Feb 02, 2018
BUY
$81.94 - $87.89 $14,093 - $15,117
172 Added 3.46%
5,142 $435,000
Q3 2017

Nov 06, 2017
BUY
$77.07 - $85.54 $383,037 - $425,133
4,970
4,970 $426,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email